Literature DB >> 3007789

Human T-cell lymphotropic virus type III infection in a cohort of homosexual men in New York City.

C E Stevens, P E Taylor, E A Zang, J M Morrison, E J Harley, S Rodriguez de Cordoba, C Bacino, R C Ting, A J Bodner, M G Sarngadharan.   

Abstract

Using blood samples collected since 1978, we investigated the epidemiology of human T-cell lymphotropic virus type III (HTLV-III), the etiologic agent of the acquired immunodeficiency syndrome, in a group of 378 homosexually active men who have resided in New York City since the acquired immunodeficiency syndrome epidemic began. The anti-HTLV-III prevalence was 6.6% in sera from 1978 or 1979, and the subsequent annual incidence of seroconversion among susceptible men ranged between 5.5% and 10.6%. The highest incidences were in recent years, even though these men reported a decrease in their sexual activity during this time. These data demonstrate the continuing risk of HTLV-III infections in the homosexual population studied and emphasize the need for more effective prevention of transmission. The year during which antibody was first present was the only factor identified that was associated with altered cell-mediated immunity in antibody-positive men. Men who became antibody positive in 1981 or earlier currently had significantly lower OKT4/OKT8 ratios than did those who seroconverted more recently. Further follow-up will be necessary to establish the reasons for this association.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007789

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

2.  The acquired immune deficiency syndrome and epidemic of infection with human immunodeficiency virus: costs of care and prevention in an inner London district.

Authors:  A M Johnson; M W Adler; J M Crown
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-23

3.  Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.

Authors:  R I Connor; H Mohri; Y Cao; D D Ho
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

4.  The emergence of HIV/AIDS in the Americas and beyond.

Authors:  M Thomas P Gilbert; Andrew Rambaut; Gabriela Wlasiuk; Thomas J Spira; Arthur E Pitchenik; Michael Worobey
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-31       Impact factor: 11.205

5.  Sexual behavior changes and HIV antibody in a cohort of New York City gay men.

Authors:  J L Martin; M A Garcia; S T Beatrice
Journal:  Am J Public Health       Date:  1989-04       Impact factor: 9.308

6.  Behavioral risk factors for HIV infection among homosexual men at a Boston community health center.

Authors:  J McCusker; A M Stoddard; K H Mayer; D N Cowan; J E Groopman
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

7.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

8.  Pilot study of AIDS risk in the general population.

Authors:  R W Jeffery; G L Burke; T L Schmid; J Ma
Journal:  Public Health Rep       Date:  1992 Jan-Feb       Impact factor: 2.792

9.  Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.

Authors:  Y Sei; P H Tsang; J P Roboz; P S Sarin; J I Wallace; J G Bekesi
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

10.  Phylodynamics of HIV-1 from a phase-III AIDS vaccine trial in North America.

Authors:  Marcos Pérez-Losada; David V Jobes; Faruk Sinangil; Keith A Crandall; David Posada; Phillip W Berman
Journal:  Mol Biol Evol       Date:  2009-10-28       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.